281 related articles for article (PubMed ID: 21910712)
41. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
42. Comparison of a fractional bipolar radiofrequency device and a fractional erbium-doped glass 1,550-nm device for the treatment of atrophic acne scars: a randomized split-face clinical study.
Rongsaard N; Rummaneethorn P
Dermatol Surg; 2014 Jan; 40(1):14-21. PubMed ID: 24267397
[TBL] [Abstract][Full Text] [Related]
43. 577-nm high-power optically pumped semiconductor laser is safe and effective in the treatment of inflammatory acne: a prospective, single-center, split-face comparative study.
Mohamed EM; Tawfik KM; Elsayed IB; Bölke E; Gerber PA
Eur J Med Res; 2021 Sep; 26(1):103. PubMed ID: 34503575
[TBL] [Abstract][Full Text] [Related]
44. Comparison of a 585-nm pulsed dye laser and a 1064-nm Nd:YAG laser for the treatment of acne scars: A randomized split-face clinical study.
Lee DH; Choi YS; Min SU; Yoon MY; Suh DH
J Am Acad Dermatol; 2009 May; 60(5):801-7. PubMed ID: 19217691
[TBL] [Abstract][Full Text] [Related]
45. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser.
Tierney E; Hanke CW
Lasers Surg Med; 2009 Oct; 41(8):555-62. PubMed ID: 19746429
[TBL] [Abstract][Full Text] [Related]
46. Effect of fluence on efficacy using the 1440 nm laser with CAP technology for the treatment of rhytids.
Lloyd JR
Lasers Surg Med; 2008 Aug; 40(6):387-9. PubMed ID: 18649383
[TBL] [Abstract][Full Text] [Related]
47. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris.
Goldberg DJ; Russell BA
J Cosmet Laser Ther; 2006 Jun; 8(2):71-5. PubMed ID: 16766484
[TBL] [Abstract][Full Text] [Related]
48. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
49. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
50. Fractional CO2 laser resurfacing for atrophic acne scars: a randomized controlled trial with blinded response evaluation.
Hedelund L; Haak CS; Togsverd-Bo K; Bogh MK; Bjerring P; Haedersdal M
Lasers Surg Med; 2012 Aug; 44(6):447-52. PubMed ID: 22766970
[TBL] [Abstract][Full Text] [Related]
51. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation.
Jørgensen GF; Hedelund L; Haedersdal M
Lasers Surg Med; 2008 Jul; 40(5):293-9. PubMed ID: 18563775
[TBL] [Abstract][Full Text] [Related]
52. A Comparative Split-Face Study Using Different Mild Purpuric and Subpurpuric Fluence Level of 595-nm Pulsed-Dye Laser for Treatment of Moderate to Severe Acne Vulgaris.
Voravutinon N; Rojanamatin J; Sadhwani D; Iyengar S; Alam M
Dermatol Surg; 2016 Mar; 42(3):403-9. PubMed ID: 26890802
[TBL] [Abstract][Full Text] [Related]
53. A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris.
Jang MS; Doh KS; Kang JS; Jeon YS; Suh KS; Kim ST
Br J Dermatol; 2011 Nov; 165(5):1095-100. PubMed ID: 21692772
[TBL] [Abstract][Full Text] [Related]
54. Role of the 585-nm pulsed dye laser in the treatment of acne in comparison with other topical therapeutic modalities.
Leheta TM
J Cosmet Laser Ther; 2009 Jun; 11(2):118-24. PubMed ID: 19391056
[TBL] [Abstract][Full Text] [Related]
55. Photopneumatic technology for the treatment of acne vulgaris.
Shamban AT; Enokibori M; Narurkar V; Wilson D
J Drugs Dermatol; 2008 Feb; 7(2):139-45. PubMed ID: 18335650
[TBL] [Abstract][Full Text] [Related]
56. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
Panchaprateep R; Munavalli G
Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
[TBL] [Abstract][Full Text] [Related]
57. The efficacy and safety of low- versus high-fluence fractional picosecond Nd:YAG 1064-nm laser in the treatment of acne scars: A randomized split-face comparison study.
Lee SH; Kim DH; Jo SJ; Lim Y; Lee JW; Lee JH; Kim TM; Kim SR; Kang J; Yoon JY; Suh DH
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12922. PubMed ID: 37898983
[TBL] [Abstract][Full Text] [Related]
58. The dual treatment of acne vulgaris using two kinds of ELOS (electro optical synergy) system: a simultaneous split-face trial.
Kim S
J Cosmet Laser Ther; 2008 Dec; 10(4):213-6. PubMed ID: 18608702
[TBL] [Abstract][Full Text] [Related]
59. A pilot study of ICG laser therapy of acne vulgaris: photodynamic and photothermolysis treatment.
Tuchin VV; Genina EA; Bashkatov AN; Simonenko GV; Odoevskaya OD; Altshuler GB
Lasers Surg Med; 2003; 33(5):296-310. PubMed ID: 14677157
[TBL] [Abstract][Full Text] [Related]
60. A Novel Combined Light-Based Treatment of Acne Vulgaris With 1,450-nm Diode Laser and 450-nm Blue Light.
Kwon HH; Choi SC; Jung JY; Bae Y; Park GH
Dermatol Surg; 2019 Sep; 45(9):1147-1154. PubMed ID: 30789515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
